Raúl obtained his Medical Doctor and PhD degree in Clinical Neurology at the University of Alicante, Spain and has a broad experience in drug discovery, clinical development and commercialization through his participation at companies such as Parke-Davis (now Pfizer), UCB Pharma, Uriach Group (now Palau Pharma) and ISDIN (from Esteve Group. He completed his education at ESADE, IESE and Harvard Business School.
Dr Insa has been working for more than 20 years in multinational pharmaceutical companies, such as Parke-Davis (now Pfizer), UCB Pharma, Uriach Group (now Palau Pharma) and ISDIN (from Esteve Group). His experience is related to drug development from drug identification to commercialization, including mainly clinical research and licensing. He was involved in the development of products like Quinapril, Tacrine, Cetirizin, Levetiracetam, Rupatadin, Dersalazine, Cimicoxib, Albaconazole, Gemfibrozil, Gabapentin, Piracetam, Levocetirizine, Nanocapsuled Cyclosporin, Disitertide, and others. He received his Medical training and his PhD in Clinical Neurology at the University of Alicante, Spain; an MBA from ESADE Business School in Barcelona and an Executive Education Program from IESE, Barcelona. He has also attended a couple of biotech leadership programs from Harvard Business School, Boston. His background includes more than 45 publications and papers, 7 chapters in books, 87 congress communications and 9 pharmaceutical patents.